文献速递关节外科

詹姆斯·A·兰德青年研究者奖:化繁为简:肌肉骨骼感染学会的所有检测对诊断假体周围关节感染都有用吗?

The James A. Rand Young Investigator's Award: Keeping It Simple: Are all Musculoskeletal Infection Society Tests Useful to Diagnose Periprosthetic Joint Infection?
PubMed 文献 · J Arthroplasty · 2024-05-27

结果显示,不使用上述先进检测时,依2018年肌肉骨骼感染学会(MSIS)标准,翻修全膝置换193例(94.6%)、翻修全髋置换156例(98.7%)可判为感染;仅3.6%病例被认为不确定。作者认为滑液α-防御素和滑液CRP在常规PJI诊断流程中可能并非必要。

要点

  • 不使用α-防御素和滑液CRP时,翻修全膝置换193例(94.6%)、翻修全髋置换156例(98.7%)符合2018年MSIS的PJI标准。
  • 翻修全膝置换177例(86.8%)、翻修全髋置换143例(90.5%)术前仅凭传统实验室检查满足MSIS主要或组合次要标准而判为PJI。
  • 全部病例中仅3.6%经术前和术中资料评估后被认为不确定。

核心结论

  • 鉴于使用现有检测在术前检查中满足PJI标准的病例比例很高,滑液α-防御素和滑液CRP检测在PJI常规诊断流程中可能并非必要。

研究设计与样本

  • 回顾性分析纳入2018至2020年间因疑似PJI行翻修全膝或全髋关节置换术且随访至少2年的患者,共审查204例翻修全膝置换和158例翻修全髋置换病例。
  • 根据是否满足2018年MSIS的PJI标准对病例进行二分类。

主要发现

  • 不使用α-防御素或滑液CRP时,几乎所有病例均符合2018年MSIS标准而被归为「感染」(翻修全膝置换:193例,94.6%;翻修全髋置换:156例,98.7%)。
  • 多数病例术前通过满足MSIS主要标准或传统实验室检查的组合次要标准而被分类为PJI(翻修全膝置换:177例,86.8%;翻修全髋置换:143例,90.5%)。
  • 一部分病例通过满足术前和术中MSIS组合标准而被分类为PJI(翻修全膝置换:16例,7.8%;翻修全髋置换:13例,8.2%)。
  • 全部病例中仅3.6%使用术前和术中资料后被认为「不确定」。

关键数值与推荐

  • 2018年MSIS的PJI诊断标准。

临床怎么用

  • 作者建议,PJI主要检查流程应基于逐步算法方法,首先使用确定诊断所需的最经济检测。
  • 作者建议,先进、商业化且昂贵的生物标志物仅在传统检测结果不确定时使用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Current data evaluating the clinical value and cost-effectiveness of advanced diagnostic tests for periprosthetic joint infection (PJI) diagnosis, including alpha-defensin and synovial C-reactive protein (CRP), is conflicting. This study aimed to evaluate the adequacy of preoperative and intraoperative PJI workups without utilizing these tests. METHODS: This retrospective analysis identified all patients who underwent revision total knee or hip arthroplasty (rTKA and rTHA, respectively) for suspected PJI between 2018 and 2020 and had a minimum follow-up of 2 years. Perioperative data and lab results were collected, and cases were dichotomized based on whether they met the 2018 Musculoskeletal Infection Society (MSIS) criteria for PJI. In total, 204 rTKA and 158 rTHA cases suspected of PJI were reviewed. RESULTS: Nearly 100% of the cases were categorized as "infected" for meeting the 2018 MSIS criteria without utilization of alpha-defensin or synovial CRP (rTKA: n = 193, 94.6%; rTHA: n = 156, 98.7%). Most cases were classified as PJI preoperatively by meeting either the major MSIS or the combinational minor MSIS criteria of traditional lab tests (rTKA: n = 177, 86.8%; rTHA: n = 143, 90.5%). A subset of cases was classified as PJI by meeting combinational preoperative and intraoperative MSIS criteria (rTKA: 16, 7.8%; rTHA: 13, 8.2%). Only 3.6% of all cases were considered "inconclusive" using preoperative and intraoperative data. CONCLUSIONS: Given the high rate of cases satisfying PJI criteria during preoperative workup using our available tests, the synovial alpha-defensin and synovial CRP tests may not be necessary in the routine diagnostic workup of PJI. We suggest that the primary PJI workup process should be based on a stepwise algorithmic approach with the most economical testing necessary to determine a diagnosis first. The use of advanced, commercialized, and costly biomarkers should be utilized only when traditional testing is indeterminate.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Kreinces JB, Ashkenazi I, Shichman I, et al. The James A. Rand Young Investigator's Award: Keeping It Simple: Are all Musculoskeletal Infection Society Tests Useful to Diagnose Periprosthetic Joint Infection? J Arthroplasty. 2024. PMID: 38810813. doi:10.1016/j.arth.2024.05.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。